Johnson & Johnson (JNJ)
219.57
+1.02
(+0.47%)
USD |
NYSE |
Jan 15, 16:00
219.27
-0.30
(-0.14%)
After-Hours: 20:00
Johnson & Johnson Market Cap: 529.01B for Jan. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.71B |
| Gilead Sciences, Inc. | 150.44B |
| Eli Lilly & Co. | 924.53B |
| Regeneron Pharmaceuticals, Inc. | 77.98B |
| Protagonist Therapeutics, Inc. | 5.298B |
Market Cap Related Metrics
| PE Ratio | 21.19 |
| PS Ratio | 5.778 |
| PEG Ratio | 0.2973 |
| Price to Book Value | 6.673 |
| Price to Free Cash Flow | 26.02 |
| Price | 219.57 |
| Earnings Yield | 4.72% |
| PEGY Ratio | 0.2878 |
| Operating PE Ratio | 22.40 |
| Normalized PE Ratio | 25.76 |